Cargando…
Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacology
Inhibitory interneurons in the brain provide the balance to excitatory signaling. On the basis of brain imaging and human genetics, a deficit in GABAergic inhibition (GABA, γ-aminobuiyric acid) has been identified as contributing to the pathophysiology of anxiety disorders, epilepsy, and schizophren...
Autor principal: | Möhler, Hanns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181687/ https://www.ncbi.nlm.nih.gov/pubmed/22034214 |
Ejemplares similares
-
Disinhibition, an emerging pharmacology of learning and memory
por: Möhler, Hanns, et al.
Publicado: (2017) -
Inflammation and the pathophysiology of Alzheimer's disease
por: Greer, M. Murphy Jr.
Publicado: (2000) -
Biochemical aspects of dementias
por: Hock, Christoph
Publicado: (2003) -
Pharmacological inhibition of diacylglycerol acyltransferase-1 and insights into postprandial gut peptide secretion
por: Maciejewski, Benjamin S, et al.
Publicado: (2017) -
The Benzodiazepines. Monographs of the Mario Negri Institute for Pharmacological Research
por: Byck, Robert
Publicado: (1974)